Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

09/08/2019 09:00

Aug 9 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            55 mln              13 mln                     
                (+315.0 pct)         (-93.3 pct)                  
  Operating     loss 617 mln        loss 712 mln                  
  Recurring     loss 616 mln        loss 717 mln                  
  Net           loss 645 mln        loss 647 mln                  
  EPS           loss 4.18 yen       loss 4.40 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T